Pages that link to "Q36087855"
Jump to navigation
Jump to search
The following pages link to The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy (Q36087855):
Displaying 50 items.
- PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells (Q21328686) (← links)
- Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia (Q24633394) (← links)
- Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? (Q26771601) (← links)
- New and emerging HDAC inhibitors for cancer treatment (Q27022413) (← links)
- Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression (Q28743074) (← links)
- Death on the slopes. Symposium on Cell Death Pathways (Q30489517) (← links)
- Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data (Q30936712) (← links)
- BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma (Q33853887) (← links)
- The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells (Q33928765) (← links)
- Autophagy: A potential target for thyroid cancer therapy (Review) (Q33933013) (← links)
- The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression (Q33934350) (← links)
- Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies (Q34399444) (← links)
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies (Q34652570) (← links)
- Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors (Q34658892) (← links)
- Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication (Q34960201) (← links)
- Autophagic and apoptotic effects of HDAC inhibitors on cancer cells (Q35001459) (← links)
- Augmenting antitumor immune responses with epigenetic modifying agents (Q35048054) (← links)
- Histone deacetylase inhibitors: emerging mechanisms of resistance. (Q35592607) (← links)
- Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells (Q35677279) (← links)
- Development of a castrate resistant transplant tumor model of prostate cancer (Q35819316) (← links)
- Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. (Q35852901) (← links)
- Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death (Q35922012) (← links)
- Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib (Q35968727) (← links)
- Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies (Q36301520) (← links)
- Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling (Q36356381) (← links)
- Unfolded protein response to autophagy as a promising druggable target for anticancer therapy (Q36403652) (← links)
- Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma (Q37211962) (← links)
- Therapeutic targeting of autophagy in disease: biology and pharmacology (Q37236107) (← links)
- Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphoma (Q37439209) (← links)
- p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors. (Q37558978) (← links)
- Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect (Q37821337) (← links)
- Autophagy as a target for anticancer therapy (Q37876679) (← links)
- HDAC inhibitors for the treatment of cutaneous T-cell lymphomas (Q37993586) (← links)
- Therapeutic targets in cancer cell metabolism and autophagy (Q38025264) (← links)
- Autophagy as a target for cancer therapy: new developments (Q38054710) (← links)
- B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies. (Q38124120) (← links)
- Histone deacetylase inhibitors and cell death (Q38217666) (← links)
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders (Q38240733) (← links)
- EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis (Q38388674) (← links)
- Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review (Q38572855) (← links)
- Histone Deacetylase Inhibitors as Anticancer Drugs (Q38696932) (← links)
- Lost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes (Q38710509) (← links)
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies (Q38811147) (← links)
- Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies (Q38812362) (← links)
- How do tumor cells respond to HDAC inhibition? (Q38817005) (← links)
- HDACs and HDAC Inhibitors in Cancer Development and Therapy (Q38947405) (← links)
- Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway (Q38974299) (← links)
- Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer (Q39069931) (← links)
- Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance (Q39197858) (← links)
- DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions (Q39271550) (← links)